Celltrion
068270.KS
#935
Rank
NZ$46.60 B
Marketcap
NZ$203.23
Share price
2.87%
Change (1 day)
4.59%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.33. an increase over its 2024 EPS that were of NZ$2.17.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025NZ$5.71163.66%
2024NZ$2.17-53.73%
2023NZ$4.68-2.08%
2022NZ$4.78-11.72%
2021NZ$5.422.03%
2020NZ$5.3182.8%
2019NZ$2.9018.31%
2018NZ$2.45-36.33%
2017NZ$3.86161.25%
2016NZ$1.482.86%
2015NZ$1.4317.84%
2014NZ$1.225.87%
2013NZ$1.15-70.85%
2012NZ$3.95134.09%
2011NZ$1.6943.59%
2010NZ$1.1774.49%
2009NZ$0.67317.8%
2008NZ$0.16-71.7%
2007NZ$0.57